{"nct_id":"NCT03291249","title":"Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM","status":"WITHDRAWN","status_verified_date":"2017-08","start_date":"2017-12-01","start_date_type":"ESTIMATED","primary_completion_date":"2018-12-01","primary_completion_date_type":"ESTIMATED","completion_date":"2019-06-01","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["TLSA"]}